The Moment Study: protocol for a mixed method observational cohort study of the Alternative Nicotine Delivery Systems (ANDS) initiation process among adult cigarette smokers.

What Was Tested

Researchers studied Therapeutic nicotine (patch, non-peptide) in this observational study publication.

Alternative Nicotine Delivery Systems (ANDS) such as e-cigarettes are battery-powered devices that aerosolize nicotine and other substances to simulate smoking without using tobacco.

Little is known about the ANDS initiation process among adult smokers.

Who Took Part

By PubMed's age tags, the people studied were adults.

This study's mixed method, 6-week longitudinal design will produce a detailed description of the ANDS initiation process among adult smokers (N=100).

Qualitative and quantitative data collection will include 3 weeks of: (1) ecological momentary assessment of patterns of cigarette/ANDS use, satisfaction, mood and craving; (2) geospatial assessment of participants' environment, including indoor and outdoor cigarette/ANDS norms and rules; (3) in-depth interviews about the meaning and utility of cigarette smoking and ANDS use; and, (4) saliva cotinine and exhaled carbon monoxide (CO) biomarkers.

How the Study Was Run

A diverse sample will be recruited with an equal number of menthol and non-menthol cigarette smokers.

As the primary independent variable, the researchers will investigate how ANDS use affects cigarette consumption.

The researchers will also examine how smoking-related and ANDS-related rules and norms surrounding product use influence cigarette and ANDS product use, and how the subjective effects of ANDS use affect ANDS perceptions, beliefs and use.

What Was Measured

The subject headings attached to it are Attitude, Biomarkers, Cohort Studies, Culture, Electronic Nicotine Delivery Systems, Longitudinal Studies and Menthol.

The authors tagged it with the keywords PUBLIC HEALTH, QUALITATIVE RESEARCH and STATISTICS & RESEARCH METHODS.

What This Means in Plain Language

This is an observational study of Therapeutic nicotine (patch, non-peptide).

The publication is from 2016 (BMJ open), a journal based in England.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.